These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16490683)

  • 1. C-reactive protein--can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease?
    Weis N; Almdal T
    Eur J Intern Med; 2006 Mar; 17(2):88-91. PubMed ID: 16490683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
    Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
    Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
    Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
    Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of sputum colour to bacterial load in acute exacerbations of COPD.
    Brusse-Keizer MG; Grotenhuis AJ; Kerstjens HA; Telgen MC; van der Palen J; Hendrix MG; van der Valk PD
    Respir Med; 2009 Apr; 103(4):601-6. PubMed ID: 19027281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
    Lee TM; Lin MS; Chang NC
    Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
    Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
    Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
    Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the quick-read C-reactive protein test in the prediction of bacterial pneumonia in the pediatric emergency department.
    Marcus N; Mor M; Amir L; Mimouni M; Waisman Y
    Eur J Emerg Med; 2008 Jun; 15(3):158-61. PubMed ID: 18460957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
    Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
    Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
    Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
    Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods.
    Gumral N; Naziroglu M; Ongel K; Beydilli ED; Ozguner F; Sutcu R; Caliskan S; Akkaya A
    Cell Biochem Funct; 2009 Jul; 27(5):276-83. PubMed ID: 19475625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care.
    Holm A; Nexoe J; Bistrup LA; Pedersen SS; Obel N; Nielsen LP; Pedersen C
    Br J Gen Pract; 2007 Jul; 57(540):547-54. PubMed ID: 17727747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study.
    Alamoudi OS
    Respirology; 2007 Mar; 12(2):283-7. PubMed ID: 17298464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative exacerbation of chronic obstructive pulmonary disease. Does it exist?
    Leo F; Venissac N; Pop D; Solli P; Filosso P; Minniti A; Radice D; Mouroux J; Spaggiari L; Pastorino U; Jougon J; Velly JF; Oliaro A
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):424-9. PubMed ID: 18226541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features.
    Bustamante-Fermosel A; De Miguel-Yanes JM; Duffort-Falcó M; Muñoz J
    Am J Emerg Med; 2007 Jun; 25(5):515-22. PubMed ID: 17543654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein to distinguish pneumonia from acute decompensated heart failure.
    Joffe E; Justo D; Mashav N; Swartzon M; Gur H; Berliner S; Paran Y
    Clin Biochem; 2009 Nov; 42(16-17):1628-34. PubMed ID: 19703436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.